Rubi Laboratories Raises $7.5M Series A Funding

Rubi Laboratories has secured $7.5 million in new investment capital.

This funding round will support the company's ongoing efforts to advance its proprietary enzyme cascade technology, which focuses on sustainable manufacturing solutions.

Rubi is developing a cell-free biocatalysis platform designed to convert waste carbon into high-value materials. These materials include cellulose textiles, chemicals, and polymer ingredients.

The company states its technology requires significantly less energy and capital investment compared to traditional manufacturing processes.

Its modular production systems are intended for broad deployment, aiming to create resilient and decarbonized supply chains that can achieve cost parity with existing products.

The $7.

5 million investment underscores growing interest in innovative approaches to sustainable manufacturing.

Rubi Laboratories plans to use the newly raised capital to scale its operations, further develop its enzyme cascade technology, and expand its market reach.

The company has already established partnerships with global manufacturers and retailers such as Walmart, H&M, and Patagonia, indicating commercial traction for its solutions.

Rubi has been recognized for its innovation, including being named World Economic Forum Technology Pioneers, MIT Tech Review 35 Innovators Under 35, European Patent Office Young Inventors Prize winners, and H&M Global Change Award winners.

This latest funding round is expected to accelerate Rubi Laboratories' mission to establish a new era of manufacturing, focusing on environmental sustainability and economic viability as it continues to grow its platform and partnerships.